Form 8-K - Current report:
SEC Accession No. 0001104659-26-065991
Filing Date
2026-05-26
Accepted
2026-05-26 07:15:24
Documents
11
Period of Report
2026-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2615548d1_8k.htm   iXBRL 8-K 42999
  Complete submission text file 0001104659-26-065991.txt   208969

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pasg-20260519.xsd EX-101.SCH 3020
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20260519_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20260519_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2615548d1_8k_htm.xml XML 3240
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 261015918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)